HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,830.00
+30.00 (0.44%)
Nov 17, 2026, 3:30 PM KST

HLB Pharmaceutical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period EndingSep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Revenue
253,848205,582137,08236,10020,54115,558
Revenue Growth
44.85%49.97%279.73%75.75%32.03%-
Gross Profit
117,125106,41686,52618,0424,4652,760
Operating Income
2,6841,0641,4741,441-5,826-3,853
Net Income
3,3754,5722,020472.66-7,060-5,447
Earnings Per Share
100.36140.0063.0034.13-521.49-455.00
EPS Growth
-29.10%122.22%84.58%---

Revenue by Segment

Fiscal Year
FY 2025FY 2024
Period EndingDec '25 Dec '24
Pharmaceutical Manufacturing - Manufacturing and Sales
153,610136,602
Pharmaceutical Manufacturing - Other
922.9480
Pharmaceutical Distribution
51,049-
Total
205,582137,082

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2019FY 2018FY 2017
Period EndingSep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Cash & Investments
80,17222,13721,99215,1639,10711,389
Total Debt
25,01120,68416,05513,1987,69414,953
Net Cash (Debt)
55,1621,4535,9381,9651,413-3,564
Net Cash Growth
471.35%-75.53%202.18%39.05%--
Net Cash Per Share
1638.2644.45185.74141.88104.39-297.72

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period EndingSep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Operating Cash Flow
-81.03568.986,8411,353-1,777-784.3
Capital Expenditures
-7,433-7,210-2,799-1,397-1,095-2,236
Free Cash Flow
-7,514-6,6424,042-43.8-2,872-3,020
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2019FY 2018FY 2017
Period EndingSep '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
Gross Margin
46.14%51.76%63.12%49.98%21.74%17.74%
Operating Margin
1.06%0.52%1.07%3.99%-28.37%-24.77%
Pretax Margin
1.43%2.43%0.85%-0.34%-27.84%-35.76%
Profit Margin
1.33%2.22%1.47%1.31%-34.37%-35.01%
FCF Margin
-2.96%-3.23%2.95%-0.12%-13.98%-19.41%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2019FY 2018FY 2017
Period EndingNov '26 Dec '25 Dec '24 Dec '19 Dec '18 Dec '17
PE Ratio
68.0649.27167.55159.09--
P/FCF Ratio
--83.73---
PS Ratio
0.881.102.472.082.855.16